SCHEMBL20482186

SCHEMBL20482186

CCC(=O)N(C)Cc1ccc(/C(N)=N/O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.43
ALDH1A1 P00352 4/20 0.43
HTT P42858 2/20 0.43
NPC1 O15118 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
HDAC1 Q13547 3/20 0.41
HDAC2 Q92769 3/20 0.41
KMT2A Q03164 1/20 0.40
AOC3 Q16853 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
TPSAB1 Q15661 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20680717 0.81 POLB (0.45) ALDH1A1HTTSMN1; SMN2KDM4EMAPT
SCHEMBL20505225 0.81 HPGD (0.43) RAB9AALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL10206928 0.77 HDAC1 (0.40) RAB9AALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL20551228 0.76 POLB (0.41) RAB9AALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL20551227 0.76 POLB (0.41) RAB9AALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL23063890 0.75 AOC3 (0.57) RAB9AALDH1A1NPC1MAPTKMT2A
SCHEMBL22229833 0.74 RAB9A (0.40) RAB9AALDH1A1NPC1GAAMAPT
SCHEMBL22229834 0.74 RAB9A (0.40) RAB9AALDH1A1NPC1GAAMAPT
SCHEMBL3163935 0.73 NPC1 (0.75) RAB9AALDH1A1NPC1SMN1; SMN2KDM4E
SCHEMBL19049393 0.73 NSD2 (0.58) RAB9AALDH1A1HTTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11425910-B2 Substituted oxadiazoles for combating phytopathogenic fungi BASF SE (DE) 2022-08-30 US disclosed
US-20210137115-A1 Substituted Oxadiazoles for Combating Phytopathogenic Fungi BASF SE (DE) 2021-05-13 US disclosed
EP-3585773-B1 SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2021-04-07 EP disclosed
WO-2018153730-A1 SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2018-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11425910-B2 Substituted oxadiazoles for combating phytopathogenic fungi CYP51A1, DPM1, TH RAB9A 4412/4885ALDH1A1 2017/4885HTT 3723/4885
US-20210137115-A1 Substituted Oxadiazoles for Combating Phytopathogenic Fungi CYP51A1, DPM1, TH RAB9A 4412/4885ALDH1A1 2017/4885HTT 3723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.